Mortality in sickle cell disease. Life expectancy and risk factors for early death.
about
Population genetics of malaria resistance in humansAntagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease allelesGenome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adultsBiologic complexity in sickle cell disease: implications for developing targeted therapeuticsHematopoietic stem cell transplantation for people with sickle cell diseasePharmacological interventions for painful sickle cell vaso-occlusive crises in adultsPhytomedicines (medicines derived from plants) for sickle cell diseaseAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseAntibiotics for treating acute chest syndrome in people with sickle cell diseaseIron supplementation for sickle cell disease during pregnancyProphylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseaseGene therapy for sickle cell diseaseMagnesium for treating sickle cell diseaseInhaled bronchodilators for acute chest syndrome in people with sickle cell diseaseAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseProphylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseasePhytomedicines (medicines derived from plants) for sickle cell diseaseAntibiotics for treating acute chest syndrome in people with sickle cell diseaseInhaled bronchodilators for acute chest syndrome in people with sickle cell diseaseBlood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseVitamin D supplementation for sickle cell diseaseHematopoietic stem cell transplantation for people with sickle cell diseaseGene therapy for sickle cell diseasePreoperative blood transfusions for sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseasePhytomedicines (medicines derived from plants) for sickle cell diseaseIron supplementation for sickle cell disease during pregnancyAngiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseGene therapy for sickle cell diseaseRegular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseHematopoietic stem cell transplantation for children with sickle cell diseaseMalaria chemoprophylaxis in sickle cell diseaseSteroid hormones for contraception in women with sickle cell diseaseAntibiotics for treating acute chest syndrome in people with sickle cell diseaseSteroid hormones for contraception in women with sickle cell diseaseMutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseEpidemiology of sickle cell disease in Saudi ArabiaSystematic review: Hydroxyurea for the treatment of adults with sickle cell diseaseGenetic dissection and prognostic modeling of overt stroke in sickle cell anemia
P2860
Q21032506-B5F64151-CC8E-434D-BAEE-3E83E8C7E565Q21261495-02458ADC-749B-4FA5-9663-AE7196F6BF7CQ21266618-663750D8-7847-4696-BB7F-113BF3E0F3CAQ21284789-821117A0-C18B-41CE-85C4-A320F592CEB7Q24185759-C40D8963-7EB6-426D-8DCD-2504B02E24BFQ24185822-B1C3AB53-6E29-4D0D-B93D-88FBEC02D4D1Q24186614-D9902AD1-E40D-413A-A044-DEC31C8126E9Q24187284-6BCB1BB8-FA79-4FBB-BB03-66140C3AC9ADQ24187355-ABC5E614-C792-4BB6-B1B5-B0B938A77CC4Q24187693-C7EA9EE0-019D-4A63-B5C4-9AE92E974740Q24188084-30FED293-A702-434B-AE58-8252D4833EB2Q24193117-DE3D6272-2E9A-4647-BE46-25FC271DBC0FQ24193246-62206397-89AB-4D0E-B14E-FC3835D499CFQ24194510-894AB14F-825D-4057-BD80-EFCC6C370B63Q24198791-428B0ACF-6BC5-4CF8-9A30-EDC3280082BCQ24200730-D3FF0317-94D8-4FEC-A64C-A07F60D6DDFAQ24201184-1F7A766C-6939-4361-B8F1-59DB5AD9730FQ24201601-1876F3E5-D27B-4A22-9557-11540A1F3D64Q24201706-DD828B76-912D-4E98-B01A-F4094FBEBFEBQ24202109-9481E3D0-EE0A-4624-8A4A-17A51B12974EQ24202463-64720687-872F-4B0D-AB57-0157AC1478D4Q24202624-E0B26F91-B74B-4DE8-9538-0B303C937E31Q24202852-04475997-AF5C-47AF-A6C6-E17EBEACFC9FQ24202911-CDB03AC1-3F36-4414-B2C8-4C99E125F1CBQ24203843-F70C4945-7609-4BB0-9109-9E57724690AEQ24234406-E797A6A8-AC25-4D27-B71F-A99A77EF4329Q24234577-23DA59FB-0AE3-4F0F-BA09-1AEBDDD85CE1Q24234773-EE216CCD-EAB3-402E-BDDB-ECEC5A3C8107Q24236018-CFDC692F-026D-4A8E-AE66-FF94C386B42AQ24236524-BF1CCA18-A9A0-4396-A218-6A3F7DF23103Q24240205-238C7AD7-1776-4B20-917E-7D4252801817Q24240994-EE754F82-80C2-4C2A-8C8A-28EC57B2B664Q24244348-B10345A0-3819-473E-94E6-CCDEE672278CQ24244478-0ABFA30E-28BE-4999-A85D-5C73880EAB5DQ24245501-E69767D1-4FA3-4034-B811-09A74669755EQ24245507-D6BCB258-35F2-42C9-A831-119EE5BD6AA5Q24606163-BF9487A7-CE45-41A6-9D53-7FABF1B37D72Q24609152-41136624-D7DC-45C5-8A80-016D0DDF9F32Q24610970-5E8200FA-EF25-42DD-B442-3484359E2697Q24621301-FF5D479C-19B9-4B78-9985-585F92483C33
P2860
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@en
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@nl
type
label
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@en
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@nl
prefLabel
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@en
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@nl
P2093
P1476
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
@en
P2093
P304
P356
10.1056/NEJM199406093302303
P407
P577
1994-06-01T00:00:00Z